Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3B, Randomized, Placebo-Controlled Study.
primary studies published RCT
Details- 2022
- Mall MA
The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial.
primary studies published RCT
Details- 2022
- Stick SM
Effect of airway clearance therapies on mucociliary clearance in adults with cystic fibrosis: A randomized controlled trial.
primary studies published RCT
Details- 2022
- Trimble A
"You're on mute!" Does pediatric CF home spirometry require physiologist supervision?
primary studies published RCT
Details- 2022
- Fettes E
Pilot RCT of a telehealth intervention to reduce symptoms of depression and anxiety in adults with cystic fibrosis.
primary studies published RCT
Details- 2022
- Bathgate CJ
Is exercise and electrostimulation effective in improving muscle strength and cardiorespiratory fitness in children with cystic fibrosis and mild-to-moderate pulmonary impairment?: Randomized controlled trial.
primary studies published RCT
Details- 2022
- Donadio MVF
Health care costs related to home spirometry in the eICE randomized trial.
primary studies published RCT
Details- 2022
- Franz N
The effect of inhaled hypertonic saline on lung structure in children aged 3-6 years with cystic fibrosis (SHIP-CT): a multicentre, randomised, double-blind, controlled trial.
primary studies published RCT
Details- 2022
- Tiddens HAWM
Impact of timing of PERT on gastrointestinal symptoms in Danish children and adolescents with CF.
primary studies published RCT
Details- 2022
- Raun AMT
Fat-Soluble Vitamins in Standard vs. Liposomal Form Enriched with Vitamin K2 in Cystic Fibrosis: A Randomized Multi-Center Trial.
primary studies published RCT
Details- 2022
- Nowak JK